Profil
Nikola Lukić
Zvanje:
Naučni saradnik
Direktni telefoni:
Lokal:
Naučna oblast:
1
Veće oblasti:
Zastita zdravlja i životne sredine,
Orcid broj:
Organizaciona jedinica:
180
DIPLOME
-
Pyk2 as modulator of cell motility
Prirodne nauke
ZVANJA
M faktor
| Kategorija | Broj | Koeficijent | Ukupno |
|---|---|---|---|
| M11 | 0 | 14 | 0 |
| M12 | 0 | 10 | 0 |
| M13 | 0 | 7 | 0 |
| M14 | 0 | 4 | 0 |
| M15 | 0 | 3 | 0 |
| M16 | 0 | 2 | 0 |
| M17 | 0 | 3 | 0 |
| M18 | 0 | 2 | 0 |
| M21a | 0 | 10 | 0 |
| M21 | 1 | 8 | 8 |
| M22 | 2 | 5 | 10 |
| M23 | 3 | 3 | 9 |
| M24 | 0 | 2 | 0 |
| M25 | 0 | 1.5 | 0 |
| M26 | 0 | 1 | 0 |
| M27 | 0 | 0.5 | 0 |
| M28a | 0 | 3.5 | 0 |
| M28b | 0 | 2.5 | 0 |
| M29a | 0 | 1.5 | 0 |
| M29b | 0 | 1.5 | 0 |
| M29v | 0 | 1 | 0 |
| M31 | 0 | 3.5 | 0 |
| M32 | 0 | 1.5 | 0 |
| M33 | 0 | 1 | 0 |
| M34 | 1 | 0.5 | 0.5 |
| M35 | 0 | 0.3 | 0 |
| M36 | 0 | 1.5 | 0 |
| M41 | 0 | 7 | 0 |
| M42 | 0 | 5 | 0 |
| M43 | 0 | 3 | 0 |
| M44 | 0 | 2 | 0 |
| M45 | 0 | 1.5 | 0 |
| M46 | 0 | 1 | 0 |
| M47 | 0 | 0.5 | 0 |
| M48 | 0 | 2 | 0 |
| M49 | 0 | 1 | 0 |
| M51 | 0 | 2 | 0 |
| M52 | 0 | 1.5 | 0 |
| M53 | 0 | 1 | 0 |
| M54 | 0 | 0.2 | 0 |
| M55 | 0 | 1 | 0 |
| M56 | 0 | 0.3 | 0 |
| M57 | 0 | 0.2 | 0 |
| M61 | 0 | 1.5 | 0 |
| M62 | 0 | 1 | 0 |
| M63 | 0 | 1 | 0 |
| M64 | 0 | 0.2 | 0 |
| M65 | 0 | 0 | 0 |
| M66 | 0 | 1 | 0 |
| M67 | 0 | 0 | 0 |
| M68 | 0 | 0 | 0 |
| M69 | 0 | 0 | 0 |
| M71 | 0 | 6 | 0 |
| M72 | 0 | 3 | 0 |
| M81 | 0 | 0 | 0 |
| M82 | 0 | 0 | 0 |
| M83 | 0 | 0 | 0 |
| M84 | 0 | 0 | 0 |
| M85 | 0 | 0 | 0 |
| M86 | 0 | 0 | 0 |
| M87 | 0 | 0 | 0 |
| M91 | 0 | 0 | 0 |
| M92 | 0 | 0 | 0 |
| M93 | 0 | 0 | 0 |
| M94 | 0 | 0 | 0 |
| M95 | 0 | 0 | 0 |
| M96 | 0 | 0 | 0 |
| M97 | 0 | 0 | 0 |
| M98 | 0 | 0 | 0 |
| M99 | 0 | 0 | 0 |
| M101 | 0 | 0 | 0 |
| M102 | 0 | 0 | 0 |
| M103 | 0 | 0 | 0 |
| M104 | 0 | 0 | 0 |
| M105 | 0 | 0 | 0 |
| M106 | 0 | 0 | 0 |
| M107 | 0 | 0 | 0 |
| M108 | 0 | 0 | 0 |
| M109 | 0 | 0 | 0 |
| M110 | 0 | 0 | 0 |
| M111 | 0 | 0 | 0 |
| M112 | 0 | 0 | 0 |
| M121 | 0 | 3 | 0 |
| M122 | 0 | 2 | 0 |
| M123 | 0 | 1 | 0 |
| M124 | 0 | 1 | 0 |
Ukupno M faktor:
27.5
NI radovi
| # | Naziv, Datum, Grupa, Vrsta | Godina | Autori | Status | Akcija |
|---|---|---|---|---|---|
| 1 |
THE ALA/ALA GENOTYPE OF PPARY PRO12 ALA POLYMORPHISM IS ASSOCIATED WITH LATE ONSET OF MULTIPLE SCLEROSIS
Arch. Biol. Sci. , / , 2013 M20 | M23 |
2013 | Никола Лукић, Александра Станковић, Евица Динчић, Маја Бундало, Крсмановић Ж, Драган Алавантић, Маја Живковић |
Odobren
|
|
| 2 |
GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients
Melanoma Research , Vojno Medicinska Akademija; , 2022 M20 | M22 |
2022 | Marija Dunjic, Nikola Lukic, Boban Djordjevic, Bojana Uzelac, Nikola Ostojic, Gordana Supic |
Odobren
|
|
| 3 |
Measuring Cell-Edge Protrusion Dynamics during Spreading using Live-Cell Microscopy
Journal of Visualized Experiments , Azrieli Faculty of Medicine, Bar-Ilan University, Israel , 2021 M20 | M23 |
2021 | Nikola Lukic, Trishna Saha, Stefanie Lapetina, Michal Gendler, Gilad Lehmann, Anthony J. Koleske, Hava Gil-Henn |
Odobren
|
|
| 4 |
Pyk2 regulates cell-edge protrusion dynamics by interacting with Crk
Molecular Biology of the Cell , , 2021 M20 | M22 |
2021 | Nikola Lukic, Stefanie Lapetina, Hanna Grobe, Kolluru D. Srikanth, Shams Twafra, Jonathan Solomon, Tal Sneh, Michal Gendler, Ronen Zaidel-Bar, Hava Gil-Henn |
Odobren
|
|
| 5 |
eNOS Glu298Asp polymorphism is associated with development of complicated plaques in patients from Serbia with advanced carotid atherosclerosis
Archives of Biological Sciences , , 2013 M20 | M23 |
2013 | Tamara Djuric, Ana Djordjevic, N. Lukic, Magdalena Andjelevski, Maja Zivkovic, Aleksandra Stankovic |
Odobren
|
|
| 6 |
Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells
Journal of Cell Biology , , 2017 M20 | M21 |
2017 | Alessandro Genna, Stefanie Lapetina, Nikola Lukic, Shams Twafra, Tomer Meirson, Ved P. Sharma, John S. Condeelis, Hava Gil-Henn |
Odobren
|
|
| 7 |
Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors
Proffered abstracts from the 17th Biennial Congress of the Metastasis Research Society , , 2019 M30 | M34 |
2019 | Tomer Meirson, Alessandro Genna, Nikola Lukic, Ved P. Sharma, Yarong Wang, John S. Condeelis, Hava Gil-Henn |
Odobren
|